169 related articles for article (PubMed ID: 1894361)
1. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii.
White WI; Evans CB; Taylor DW
Infect Immun; 1991 Oct; 59(10):3547-54. PubMed ID: 1894361
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
Ak M; Bower JH; Hoffman SL; Sedegah M; Lees A; Carter M; Beaudoin RL; Charoenvit Y
Infect Immun; 1993 Jun; 61(6):2493-7. PubMed ID: 8500885
[TBL] [Abstract][Full Text] [Related]
3. Inbred mice infected with Plasmodium yoelii differ in their antimalarial immunoglobulin isotype response.
Taylor DW; Pacheco E; Evans CB; Asofsky R
Parasite Immunol; 1988 Jan; 10(1):33-46. PubMed ID: 3353128
[TBL] [Abstract][Full Text] [Related]
4. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
[TBL] [Abstract][Full Text] [Related]
5. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
Adame-Gallegos JR; Shi J; McIntosh RS; Pleass RJ
Exp Parasitol; 2012 Apr; 130(4):384-93. PubMed ID: 22343045
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.
Kedzierski L; Black CG; Stowers AW; Goschnick MW; Kaslow DC; Coppel RL
Vaccine; 2001 Sep; 19(32):4661-8. PubMed ID: 11535314
[TBL] [Abstract][Full Text] [Related]
7. Adaptive immune responses mediated age-related Plasmodium yoelii 17XL and 17XNL infections in 4 and 8-week-old BALB/c mice.
Wang QB; Du YT; Liu F; Sun XD; Sun X; Chen G; Pang W; Cao YM
BMC Immunol; 2021 Jan; 22(1):6. PubMed ID: 33430765
[TBL] [Abstract][Full Text] [Related]
8. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
Rotman HL; Daly TM; Clynes R; Long CA
J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice.
Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM
Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells play a major role for IgM and IgG anti-DNA production in mice infected with Plasmodium yoelii.
Fossati L; Merino J; Izui S
Clin Exp Immunol; 1990 Feb; 79(2):291-6. PubMed ID: 1968798
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of the different developmental stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi chabaudi to hyperimmune serum, immunoglobulin (Ig)G1, IgG2a and F(ab')2 fragments.
Cavinato RA; Bastos KR; Sardinha LR; Elias RM; Alvarez JM; d'Império Lima MR
Parasite Immunol; 2001 Nov; 23(11):587-97. PubMed ID: 11703810
[TBL] [Abstract][Full Text] [Related]
12. Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.
Eslava I; Payares G; Pernia BM; Holder AA; Spencer LM
Malar J; 2010 Feb; 9():46. PubMed ID: 20146804
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.
Vukovic P; Hogarth PM; Barnes N; Kaslow DC; Good MF
Infect Immun; 2000 May; 68(5):3019-22. PubMed ID: 10769007
[TBL] [Abstract][Full Text] [Related]
14. Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome.
Llewellyn D; de Cassan SC; Williams AR; Douglas AD; Forbes EK; Adame-Gallegos JR; Shi J; Pleass RJ; Draper SJ
J Leukoc Biol; 2014 Feb; 95(2):369-82. PubMed ID: 24163420
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E-deficient diets enriched with fish oil suppress lethal Plasmodium yoelii infections in athymic and scid/bg mice.
Taylor DW; Levander OA; Krishna VR; Evans CB; Morris VC; Barta JR
Infect Immun; 1997 Jan; 65(1):197-202. PubMed ID: 8975912
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.
Matsumoto S; Yukitake H; Kanbara H; Yamada H; Kitamura A; Yamada T
Vaccine; 2000 Nov; 19(7-8):779-87. PubMed ID: 11115699
[TBL] [Abstract][Full Text] [Related]
17. Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections.
Smith EC; Taylor-Robinson AW
Parasitol Res; 2003 Jan; 89(1):26-33. PubMed ID: 12474040
[TBL] [Abstract][Full Text] [Related]
18. Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.
Shi Q; Cernetich A; Daly TM; Galvan G; Vaidya AB; Bergman LW; Burns JM
Infect Immun; 2005 Oct; 73(10):6363-71. PubMed ID: 16177307
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium yoelii: characterization of a protective idiotype during malarial infection in mice.
Majarian WR; Daly TM; Burns JM; Long CA
Exp Parasitol; 1988 Dec; 67(2):227-37. PubMed ID: 2461316
[TBL] [Abstract][Full Text] [Related]
20. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
